6 Stocks, One Common Theme: Leading Groups, Leading Stocks
1 extracted signal · 1 resolved · 0 still active
Our Mission WinnersIndependent analyst profile- Source published
- 21 Sept 2026, 17:00 UTC
- Recorded by Tahlil Plus
- 21 Sept 2026, 20:11 UTC

AI-generated source summary
The analysis covers three stocks: Intel (INTC), Moderna (MRNA), and Sandisk (SNDK). For INTC, the current price is around 100, with a target of 111.37. The analysis suggests a bullish trend, with a fail bound at 98, indicating that a break below this level would invalidate the bullish outlook. For MRNA, the current price is approximately 158, with a target of 162. The suggested fail bound is 149, implying that if the price drops below this, the bullish setup is compromised. For SNDK, the current price is near 1791.82, and the analysis points to a target of 1800. The fail bound is set at 1750, meaning a fall below this level invalidates the bullish prediction. All three stocks are analyzed on a daily timeframe and are presented as having bullish actual and predicted market trends. The speaker emphasizes the importance of fundamental and technical analysis, focusing on earnings, sales, and price action with volume confirmation.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Our Mission Winners
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
